Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Purple Biotech Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 13 | 12 | −1 |
| Shares | 762.7K | 1.15M | +388.0K (+50.9%) |
| Value | $3.72M | $5.27M | +$1.55M (+41.6%) |
New holders (4)
Institutions that held Purple Biotech Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 736,019 | $3.37M | 0.01% |
| Geode Capital Management, LLC | 12,666 | $57.0K | 0.00% |
| Venture Visionary Partners LLC | 10,068 | $46.0K | 0.00% |
| Meridian Wealth Partners, LLC | 295 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Purple Biotech Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Sabby Management, LLC | 50,590 | $247.0K |
| Citadel Advisors LLC | 28,177 | $138.0K |
| OrbiMed Advisors LLC | 17,712 | $86.0K |
| Advisory Services Network, LLC | 1,945 | $9.00K |
| FMR LLC | 1 | $0 |